Fundraising Fox

Pear Therapeutics

Boston, US · Founded 2013 · Delaware corporation · 4 known investors

Pioneering the development of prescription digital therapeutics.

Healthtech

Founders & leadership

AN
Antoun NabhanExecutive Officer
CM
Corey McCannExecutive Officer, Director
AS
Andrew SchwabDirector
TP
Timothy PetersenDirector
CG
Christopher GuiffreExecutive Officer
ZL
Zack LynchDirector

Investors · 4

JAZZ Venture PartnersSan Francisco · $100K – $20M
5AM VenturesreportedBoston · $100K – $4M
Arboretum VenturesreportedAnn Arbor · $5M – $15Mvia Tim Petersen · board
General CatalystreportedSan Francisco · $30Mvia Elena Viboch · board

Reported raises · per SEC filings

Form D private placements
▶$132MraisedMar 2021 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew SchwabDirector
  • Elena VibochDirector
  • Nancy SchlichtingDirector
  • Christopher GuiffreExecutive Officer
  • Julia StrandbergExecutive Officer
  • Yuri MaricichExecutive Officer
  • Ronan O'BrienExecutive Officer
  • Corey McCannExecutive Officer, Director
  • Zack LynchDirector
  • Timothy PetersenDirector
Offering amount
$132M
Amount sold
$132M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$64.3MraisedJan 2019 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy PetersenDirector
  • Andrew SchwabDirector
  • Jeremy GilbertExecutive Officer
  • Alex WaldronExecutive Officer
  • Hongjie HuDirector
  • Corey McCannExecutive Officer, Director
  • Zack LynchDirector
  • Christopher GuiffreExecutive Officer
  • Yuri MaricichExecutive Officer
Offering amount
$65M
Amount sold
$64.3M
First sale
Dec 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$46MraisedJan 2018 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Antoun NabhanExecutive Officer
  • Corey McCannExecutive Officer, Director
  • Andrew SchwabDirector
  • Timothy PetersenDirector
  • Christopher GuiffreExecutive Officer
  • Zack LynchDirector
Offering amount
$51M
Amount sold
$46M
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.4MraisedFeb 2016 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew J. SchwabDirector
  • Tim PetersenDirector
  • Zack LynchDirector
  • Corey McCannExecutive Officer, Director
Offering amount
$20.4M
Amount sold
$12.4M
First sale
Jan 2016
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.